Suppr超能文献

与EuroSCORE 预测的 CABG 短期预后相比,接受无保护左主干冠状动脉支架 PCI 的患者具有良好的长期生存:长期结果的临床决定因素。

Favorable long-term survival in patients undergoing stent PCI of unprotected left main coronary artery compared to predicted short-term prognosis of CABG estimated by EuroSCORE: clinical determinants of long-term outcome.

机构信息

Department of Cardiology, Johann Wolfgang Goethe-University Frankfurt, D-60590 Frankfurt, Germany.

出版信息

J Interv Cardiol. 2009 Aug;22(4):311-9. doi: 10.1111/j.1540-8183.2009.00480.x.

Abstract

AIMS/METHODS: The long-term outcome of patients (pts) undergoing percutaneous coronary intervention (PCI) of unprotected left main coronary artery (LMCA) is unclear so far. We prospectively investigated the outcome of 102 consecutive patients who underwent stent PCI of unprotected LMCA. Patients were divided according to clinical indication for PCI: stable coronary artery disease (CAD) (N = 60), NSTEMI (N = 18), STEMI (N = 24). Expected in-hospital mortality of coronary artery bypass grafting (CABG) was calculated using the European System for Cardiac Operative Risk Evaluation (EuroSCORE) and compared to the observed survival rate during long-term follow-up (mean 1.8 +/- 1.2 years).

RESULTS

The observed 30-day mortality was 1.7% (1/60 pts) in patients with stable CAD, 11% (2/18 pts) in NSTEMI patients, and 13% (3/24 pts) in STEMI patients. The observed mortality was lower than the predicted mortality of CABG as calculated by the logistic EuroSCORE. Using receiver-operator characteristics curves (ROC), EuroSCORE demonstrated a high predictive value for both 30-day mortality as well as 1-year mortality (AUC > 0.8; P < 0.01). Prognostically relevant patient related factors (P < 0.01) included severely reduced left ventricular ejection fraction (HR 3.24), ACS (HR 3.18), STEMI (HR: 3.01), Killip class IV (HR 7.69), occurrence of neoplastic disease (HR 3.97), and elevated CRP (HR 3.86).

CONCLUSIONS

LMCA-PCI was associated with lower long-term mortality rates compared to the estimated mortality of CABG. This prospective observational study suggests that DES-PCI of unprotected LMCA in "all-comers" can be carried out with reasonable risk.

摘要

目的/方法:目前尚不清楚接受经皮冠状动脉介入治疗(PCI)的无保护左主干冠状动脉(LMCA)的患者的长期预后。我们前瞻性研究了 102 例连续接受无保护 LMCA 支架 PCI 的患者的结果。根据 PCI 的临床指征将患者分为:稳定型冠心病(CAD)(N=60)、非 ST 段抬高型心肌梗死(NSTEMI)(N=18)、ST 段抬高型心肌梗死(STEMI)(N=24)。使用欧洲心脏手术风险评估系统(EuroSCORE)计算冠状动脉旁路移植术(CABG)的预期住院死亡率,并与长期随访期间的观察生存率(平均 1.8±1.2 年)进行比较。

结果

稳定型 CAD 患者的 30 天死亡率为 1.7%(1/60 例),NSTEMI 患者为 11%(2/18 例),STEMI 患者为 13%(3/24 例)。观察到的死亡率低于通过逻辑 EuroSCORE 计算的 CABG 的预测死亡率。使用接收者操作特征曲线(ROC),EuroSCORE 对 30 天死亡率和 1 年死亡率均具有较高的预测价值(AUC>0.8;P<0.01)。具有预后意义的患者相关因素(P<0.01)包括严重左心室射血分数降低(HR 3.24)、ACS(HR 3.18)、STEMI(HR:3.01)、Killip 分级 IV(HR 7.69)、发生恶性肿瘤疾病(HR 3.97)和 CRP 升高(HR 3.86)。

结论

与 CABG 的估计死亡率相比,LMCA-PCI 与较低的长期死亡率相关。这项前瞻性观察研究表明,在“所有患者”中,对无保护 LMCA 进行 DES-PCI 可以在合理的风险下进行。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验